Michelle Dawson posts

Post published on Twitter/X on 2 Jun 2022 08:00

Back to posts Previous post Next post
Twitter/X Clinical trial clinicaltrials.gov Extract quoted in the post Question asked by Dawson in the post External link integrated into the post Autism terms
Open original post

Information about the link integrated into the post

Clinical trial

Yale University (2018). Translating Neuroprediction Into Precision Medicine Via Brain Priming. ClinicalTrials.gov. Yale University.

More information

Structured cited links

1 cited resource

Clinical trial Fetched Post clinicaltrials.gov

Yale University (2018). Translating Neuroprediction Into Precision Medicine Via Brain Priming. ClinicalTrials.gov. Yale University.

Publication date
7 Dec 2018
Identifier
NCT03370510
Authors
Yale University
Source
ClinicalTrials.gov
Reference type
clinical_trial
Publisher
Yale University
Metadata source
clinicaltrials.gov

Abstract

The present study examines the impact of oxytocin (OXT) and Pivotal Response Treatment (PRT) on the development of language, social, and play skills in young children with Autism Spectrum Disorder (ASD). The purpose of this study is to examine the impact of OXT as an enhancer of response to PRT. Participants will be randomly assigned to either an intranasal OXT group or a placebo group. Neither the research team nor the participants will know or choose which group the participant is assigned to. Children in both groups will participate in a 16-week trial of PRT. The trial will test the hypothesis that children with lower levels of activity in and functional connectivity among certain PRT-response brain regions will benefit more from the administration of OXT vs. placebo as an enhancer to a 16-week trial of PRT.

Open source Link to cited source